Trabectedin and Irinotecan for Refractory Pediatric Sarcomas

NCT02509234 · clinicaltrials.gov ↗

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Childhood Soft Tissue Sarcoma
Recurrent Ewing Sarcoma
Recurrent Rhabdomyosarcoma

Interventions

DRUG: Combined chemotherapy with trabectedin followed by irinotecan

Sponsor

Technical University of Munich